|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8730 EUR | +1.28% |
|
-4.07% | -43.16% |
| 06-10 | AB Science presents new data on Masitinib |  |
| 05-18 | AB Science S.A. announced that it has received $2.989368 million in funding | CI |
Company Valuation: AB Science
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 895.3 | 332.2 | 180.9 | 57.55 | 65.98 | 65.98 | - |
| Change | - | - | -45.55% | -68.19% | 14.64% | 0% | - |
| Enterprise Value (EV) | 895.3 | 332.2 | 180.9 | 57.55 | 65.98 | 65.98 | 65.98 |
| Change | - | - | -45.55% | -68.19% | 14.64% | 0% | 0% |
| P/E Ratio | - | -24.4x | -17.8x | -5.88x | - | - | - |
| PBR | - | - | - | - | - | - | - |
| PEG | - | - | 0.6x | 0.2x | - | - | - |
| Capitalization / Revenue | 566x | - | 187x | 53.7x | 95.4x | 55x | 50.8x |
| EV / Revenue | 0x | - | 0x | 0x | 60x | 55x | 50.8x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | - | - | -0x | -0x | -11x | -10.2x | -10.3x |
| EV / FCF | - | - | -0x | - | -11x | -10.3x | -18.3x |
| FCF Yield | - | - | -9.52% | - | -4.08% | -9.7% | -5.46% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | - | -0.29 | -0.2 | -0.15 | - | - | - |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 1.583 | - | 0.97 | 1.072 | 1.174 | 1.2 | 1.3 |
| EBITDA | - | - | -11.16 | -5.416 | - | - | - |
| EBIT 1 | - | - | -13.43 | -6.083 | 0.639 | -6.5 | -6.4 |
| Net income | - | -13.62 | -10.05 | -7.831 | - | - | - |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 19.6600 | 7.0900 | 3.5550 | 0.8820 | 0.8620 | 0.8620 | 0.8620 |
| Nbr of stocks (in thousands) | 45,540 | 46,861 | 50,891 | 65,248 | 76,539 | 76,539 | - |
| Announcement Date | 30/4/21 | 1/3/23 | 15/5/24 | 13/5/25 | 13/5/26 | - | - |
1EUR in Million2EUR
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 76.56M | |
| 51.38x | 4.8x | 19.5x | 2.9% | 284B | |
| 22.31x | 3.09x | 10.97x | 1.76% | 66.62B | |
| 10.34x | 5.33x | 8.21x | - | 8.26B | |
| 15.61x | 1.94x | 6.68x | 2.86% | 7.84B | |
| 22.32x | 6.69x | 18.29x | -.--% | 4.6B | |
| 43.48x | 2.46x | 30.01x | 0.71% | 3.87B | |
| 27.03x | 5.19x | 14.84x | - | 3.15B | |
| 100.57x | - | - | -.--% | 2.53B | |
| Average | 36.63x | 4.21x | 15.50x | 1.37% | 42.38B | |
| Weighted average by Cap. | 44.37x | 4.45x | 17.55x | 2.62% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AB Stock
- Valuation AB Science
Select your edition
All financial news and data tailored to specific country editions
